Synonyms: Cozaar® | DuP 753 | MK-954
losartan is an approved drug (FDA (1995))
Compound class:
Synthetic organic
Comment: Losartan is an angiotensin II (AT2) receptor antagonist drug.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖![]() View more information in the IUPHAR Pharmacology Education Project: losartan |
|
Selectivity at GPCRs | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
Targets where the ligand is described in the comment field | |
Target | Comment |
Urate anion exchanger 1 | URAT1 is expressed in the proximal tubule of the kidney and regulates uric acid excretion from the body. Inhibitors of this transporter, such as losartan, find clinical utility in managing hyperuricemia in patients with gout [1,3]. |
Ligand mentioned in the following text fields |
Angiotensin receptors overview |